Global Psychedelic Medicine Market Research Report 2024

List of Figures, Tables and Charts Available in Global Psychedelic Medicine Market Research Report 2024

List of Tables
Table 1. Global Psychedelic Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Psilocybin
Table 3. Key Players of LSD
Table 4. Key Players of MDMA
Table 5. Key Players of DMT
Table 6. Key Players of Ketamine
Table 7. Key Players of Others
Table 8. Global Psychedelic Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Psychedelic Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Psychedelic Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Psychedelic Medicine Market Share by Region (2019-2024)
Table 12. Global Psychedelic Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Psychedelic Medicine Market Share by Region (2025-2030)
Table 14. Psychedelic Medicine Market Trends
Table 15. Psychedelic Medicine Market Drivers
Table 16. Psychedelic Medicine Market Challenges
Table 17. Psychedelic Medicine Market Restraints
Table 18. Global Psychedelic Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Psychedelic Medicine Market Share by Players (2019-2024)
Table 20. Global Top Psychedelic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychedelic Medicine as of 2023)
Table 21. Ranking of Global Top Psychedelic Medicine Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Psychedelic Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Psychedelic Medicine Product Solution and Service
Table 25. Date of Enter into Psychedelic Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Psychedelic Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Psychedelic Medicine Revenue Market Share by Type (2019-2024)
Table 29. Global Psychedelic Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Psychedelic Medicine Revenue Market Share by Type (2025-2030)
Table 31. Global Psychedelic Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Psychedelic Medicine Revenue Market Share by Application (2019-2024)
Table 33. Global Psychedelic Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Psychedelic Medicine Revenue Market Share by Application (2025-2030)
Table 35. North America Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Psychedelic Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Psychedelic Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Psychedelic Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Psychedelic Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Psychedelic Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Psychedelic Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Psychedelic Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Psychedelic Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Psychedelic Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Psychedelic Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Psychedelic Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Psychedelic Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 50. COMPASS Pathways PLC Company Detail
Table 51. COMPASS Pathways PLC Business Overview
Table 52. COMPASS Pathways PLC Psychedelic Medicine Product
Table 53. COMPASS Pathways PLC Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 54. COMPASS Pathways PLC Recent Development
Table 55. Pfizer Company Detail
Table 56. Pfizer Business Overview
Table 57. Pfizer Psychedelic Medicine Product
Table 58. Pfizer Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 59. Pfizer Recent Development
Table 60. Eli Lilly Company Detail
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Psychedelic Medicine Product
Table 63. Eli Lilly Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 64. Eli Lilly Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Psychedelic Medicine Product
Table 68. GlaxoSmithKline Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Cybin Inc Company Detail
Table 71. Cybin Inc Business Overview
Table 72. Cybin Inc Psychedelic Medicine Product
Table 73. Cybin Inc Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 74. Cybin Inc Recent Development
Table 75. Field Trip Health Company Detail
Table 76. Field Trip Health Business Overview
Table 77. Field Trip Health Psychedelic Medicine Product
Table 78. Field Trip Health Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 79. Field Trip Health Recent Development
Table 80. ATAI Life Sciences Company Detail
Table 81. ATAI Life Sciences Business Overview
Table 82. ATAI Life Sciences Psychedelic Medicine Product
Table 83. ATAI Life Sciences Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 84. ATAI Life Sciences Recent Development
Table 85. NUMINUS WELLNESS Company Detail
Table 86. NUMINUS WELLNESS Business Overview
Table 87. NUMINUS WELLNESS Psychedelic Medicine Product
Table 88. NUMINUS WELLNESS Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 89. NUMINUS WELLNESS Recent Development
Table 90. MindMed Company Detail
Table 91. MindMed Business Overview
Table 92. MindMed Psychedelic Medicine Product
Table 93. MindMed Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 94. MindMed Recent Development
Table 95. HAVN Life Sciences Company Detail
Table 96. HAVN Life Sciences Business Overview
Table 97. HAVN Life Sciences Psychedelic Medicine Product
Table 98. HAVN Life Sciences Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 99. HAVN Life Sciences Recent Development
Table 100. Seelos Therapeutics Company Detail
Table 101. Seelos Therapeutics Business Overview
Table 102. Seelos Therapeutics Psychedelic Medicine Product
Table 103. Seelos Therapeutics Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 104. Seelos Therapeutics Recent Development
Table 105. Jannsen Company Detail
Table 106. Jannsen Business Overview
Table 107. Jannsen Psychedelic Medicine Product
Table 108. Jannsen Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 109. Jannsen Recent Development
Table 110. Acadia Pharmaceuticals Company Detail
Table 111. Acadia Pharmaceuticals Business Overview
Table 112. Acadia Pharmaceuticals Psychedelic Medicine Product
Table 113. Acadia Pharmaceuticals Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 114. Acadia Pharmaceuticals Recent Development
Table 115. Intellipharmaceutics Company Detail
Table 116. Intellipharmaceutics Business Overview
Table 117. Intellipharmaceutics Psychedelic Medicine Product
Table 118. Intellipharmaceutics Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 119. Intellipharmaceutics Recent Development
Table 120. Revive Therapeutics Company Detail
Table 121. Revive Therapeutics Business Overview
Table 122. Revive Therapeutics Psychedelic Medicine Product
Table 123. Revive Therapeutics Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 124. Revive Therapeutics Recent Development
Table 125. Mydecine Innovations Group Company Detail
Table 126. Mydecine Innovations Group Business Overview
Table 127. Mydecine Innovations Group Psychedelic Medicine Product
Table 128. Mydecine Innovations Group Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 129. Mydecine Innovations Group Recent Development
Table 130. Red Light Holland Company Detail
Table 131. Red Light Holland Business Overview
Table 132. Red Light Holland Psychedelic Medicine Product
Table 133. Red Light Holland Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 134. Red Light Holland Recent Development
Table 135. Braxia Scientific Company Detail
Table 136. Braxia Scientific Business Overview
Table 137. Braxia Scientific Psychedelic Medicine Product
Table 138. Braxia Scientific Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 139. Braxia Scientific Recent Development
Table 140. Mind Cure Health Company Detail
Table 141. Mind Cure Health Business Overview
Table 142. Mind Cure Health Psychedelic Medicine Product
Table 143. Mind Cure Health Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 144. Mind Cure Health Recent Development
Table 145. Entheon Biomedical Company Detail
Table 146. Entheon Biomedical Business Overview
Table 147. Entheon Biomedical Psychedelic Medicine Product
Table 148. Entheon Biomedical Revenue in Psychedelic Medicine Business (2019-2024) & (US$ Million)
Table 149. Entheon Biomedical Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychedelic Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Psychedelic Medicine Market Share by Type: 2023 VS 2030
Figure 3. Psilocybin Features
Figure 4. LSD Features
Figure 5. MDMA Features
Figure 6. DMT Features
Figure 7. Ketamine Features
Figure 8. Others Features
Figure 9. Global Psychedelic Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Psychedelic Medicine Market Share by Application: 2023 VS 2030
Figure 11. Depressive Disorders Case Studies
Figure 12. Post-Traumatic Stress Disorders Case Studies
Figure 13. Substance Abuse Disorders Case Studies
Figure 14. Obsessive Compulsive Disorders Case Studies
Figure 15. Others Case Studies
Figure 16. Psychedelic Medicine Report Years Considered
Figure 17. Global Psychedelic Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Psychedelic Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Psychedelic Medicine Market Share by Region: 2023 VS 2030
Figure 20. Global Psychedelic Medicine Market Share by Players in 2023
Figure 21. Global Top Psychedelic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychedelic Medicine as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Psychedelic Medicine Revenue in 2023
Figure 23. North America Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Psychedelic Medicine Market Share by Country (2019-2030)
Figure 25. United States Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Psychedelic Medicine Market Share by Country (2019-2030)
Figure 29. Germany Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Psychedelic Medicine Market Share by Region (2019-2030)
Figure 37. China Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Psychedelic Medicine Market Share by Country (2019-2030)
Figure 45. Mexico Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Psychedelic Medicine Market Share by Country (2019-2030)
Figure 49. Turkey Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Psychedelic Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. COMPASS Pathways PLC Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 52. Pfizer Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 53. Eli Lilly Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 55. Cybin Inc Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 56. Field Trip Health Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 57. ATAI Life Sciences Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 58. NUMINUS WELLNESS Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 59. MindMed Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 60. HAVN Life Sciences Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 61. Seelos Therapeutics Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 62. Jannsen Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 63. Acadia Pharmaceuticals Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 64. Intellipharmaceutics Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 65. Revive Therapeutics Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 66. Mydecine Innovations Group Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 67. Red Light Holland Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 68. Braxia Scientific Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 69. Mind Cure Health Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 70. Entheon Biomedical Revenue Growth Rate in Psychedelic Medicine Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed